Targeting APLN/APLNR Improves Anti-Angiogenic Efficiency and Blunts Pro-Invasive Side Effects of VEGFA/VEGFR2-blockade in Glioblastoma
Cancer Research - United States
doi 10.1158/0008-5472.can-18-0881
Full Text
Open PDFAbstract
Available in full text
Date
February 4, 2019
Authors
Publisher
American Association for Cancer Research (AACR)